Glaxo Flovent Sales Reach $517 Mil.; Respiratory Products are $3 Bil.
Executive Summary
Glaxo Wellcome Flovent inhaler sales jumped 88% in 1997 in terms of constant exchange rates, Glaxo reported during a Feb. 19 teleconference. Sales for Flovent reached #315 mil., or $517 mil., with the "strongest sales growth" in the U.S.